CEBPA and acute myeloid leukemia: Although biallelic CEBPA mutations have traditionally been linked to favorable outcomes in AML, a recent study by Tarlock et al. evaluated the significance of mutations specifically affecting the basic leucine zipper (bZip) domain of CEBPA [26].